http___youloveserver.ru_ga_Erectalis.html_1.xml
1.1 2.1 2.2 2.3 2.4 2.5 2.6 2.7 3.1 3.2 3.3 4.1 4.2 4.3 4.4 4.5 4.6 5.1 5.2
Softgel Capsules 20 mg Tadagra Since the introduction of sildenafil in 1998 PDE-5 inhibitors are due to their ease of use, the drug of choice for the treatment of erectile dysfunction. Nevertheless, the previously used treatment options quite yet their significance. Tadalafil vardenafil l and offer a therapeutic option to Sildenafi l The efficacy and side effects are comparable for all three substances. Tadalafil works in relation to the selective PDE-6 as sildenafil and call out only in isolated cases blurred vision. Studies, all three PDE-5 inhibitors are not yet directly comparable, so that a final assessment is not currently possible. The available studies are due to different patient selection criteria and target difficult to assimilate. In some studies with tadalafil or vardenafil patients who had not responded to sildenafil were excluded, allowing comparison of response rates is virtually impossible (26). A much discussed question is the possible interaction between the erection-enhancing drugs, sexual activity and cardiovascular disease. Although clinical studies have demonstrated no increase in cardiac risk, cardiac disease seems to appear based on individual case reports, a careful risk-benefit assessment. It is important that PDE-5 inhibitors should not be taken with nitrates. Tadalafil has for its half-life of 17.5 hours with approximately 24 hours (36 hours), the longest duration of action and could therefore act with an intake every two days consecutively in theory. A daily intake is not recommended. If properly applied, the longer effect does not seem to cause more side effects. Rather, it means more freedom for patients to use, and thus reduces the pressure to succeed at the same time. Moreover, since the use of the food and alcohol consumption is independent, sexual activity must be planned for less than it is at the other PDE-5 inhibitors is the case. Vardenafil on the other hand, flooded the fastest, so that the effect occurs frequently after 20 minutes. Which of the three drugs will be given preference is ultimately an individual decision of the treating physician and the patient. The price will play a minor role in this decision, since treatment costs are high for a similar application for all three drugs in the doses.
1.1 2.1 2.2 2.3 2.4 2.5 2.6 3.1 3.2 3.3 4.1 4.2 4.3 4.4 4.5 4.6 5.1 5.2
Erectalis Ó tugadh sildenafil i 1998 PDE-5 inhibitors atá mar gheall ar a n-éasca le húsáid, an druga de rogha le haghaidh cóireáil erectile dysfunction. Mar sin féin, na roghanna cóireála a úsáideadh roimhe go leor go fóill a dtábhacht. Tadalafil vardenafil l agus a thairiscint rogha teiripeacha do Sildenafi l An éifeachtúlacht agus fo-iarsmaí inchomparáide do na trí substaintí. Oibríonn Tadalafil maidir le roghnach PDE-6 mar sildenafil agus glaoch amach i gcorrchás amháin blurred fís. Staidéir, ní léir na trí PDE-5 inhibitors fós inchurtha go díreach, mar sin nach bhfuil measúnú deiridh féideartha faoi láthair. teacht ar an staidéar mar gheall ar chritéir roghnúcháin éagsúla othar agus sprioc deacair a chomhshamhlú. I roinnt staidéir le hothair tadalafil nó vardenafil nár thug freagra ar sildenafil eisiamh, ag ligean a chur i gcomparáid rátaí freagartha bhfuil sé beagnach dodhéanta (26). Tá ceist i bhfad pléadh an idirghníomhaíocht is féidir idir an tógáil-fheabhsú drugaí, gníomhaíocht ghnéasach agus galar cardashoithíoch. Cé go bhfuil staidéir chliniciúla léirigh aon mhéadú riosca cairdiach, is cosúil galar cairdiach a bheith i láthair bunaithe ar thuarascálacha gcás aonair, measúnú riosca agus tairbhe cúramach. Tá sé tábhachtach nach PDE-5 inhibitors a ghlacadh le níotráití. Tadalafil Tá ar a leathré de 17.5 uair an chloig thart ar 24 uair an chloig (36 uair an chloig), ré is faide de ghníomhaíocht agus dá bhrí sin d'fhéadfadh gníomhú le iontógáil gach dhá lá i ndiaidh a chéile go teoiriciúil. Ní Tá iontógáil laethúil molta. Má chuirtear i bhfeidhm i gceart, nach bhfuil an éifeacht níos faide is cosúil a bheith ina chúis le fo-éifeachtaí níos mó. Ina ionad sin, ciallaíonn sé níos mó saoirse d'othair a úsáid, agus dá bhrí sin laghdaíonn an brú chun cinn ag an am céanna. Ina theannta sin, ós rud é go bhfuil an úsáid an tomhaltas bia agus alcól neamhspleách, gníomhaíocht ghnéasach a phleanáil ar feadh níos lú ná mar atá ag an PDE-5 inhibitors eile an cás. Vardenafil ar an láimh eile, faoi uisce an tapúla, ionas go bhfuil an éifeacht go minic tar éis 20 nóiméad. Cé acu de na trí drugaí a thabhairt is rogha deireadh thiar cinneadh aonair an lia cóireála agus an t-othar. Beidh an praghas ról saorga sa chinneadh, ós rud é go bhfuil na costais chóireála arda do chur chun feidhme den chineál céanna do na trí drugaí sna dáileoga.